文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

流感感染所致急性呼吸衰竭成人患者的临床特征与预后因素

[Clinical characteristics and prognostic factors of adult patients with acute respiratory failure due to influenza infection].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01
一句话结论流感相关急性呼吸衰竭患者ICU病死率39.4%,入ICU时APACHE II评分、PaO2/FiO2和淋巴细胞计数是死亡的独立预测因素。

该回顾性研究纳入2018年1月至2020年1月郑州大学第一附属医院和郑州市第六人民医院ICU收治的104例确诊流感感染合并急性呼吸衰竭成人患者,按出院前是否死亡分为存活组和死亡组。结果显示医院病死率39.4%(41例),91.3%为甲型流感。死亡组入ICU时呼吸频率、APACHE II评分、PCT更高,心血管疾病比例和侵入性机械通气比例更高,而PaO2/FiO2、淋巴细胞计数、血红蛋白、血小板计数、T淋巴细胞计数、CD4+和CD8+计数更低。多因素Logistic分析显示APACHE II评分(OR=1.195,95%CI 1.041-1.372,P=0.011)、淋巴细胞计数(OR=0.063,95%CI 0.011-0.369,P=0.002)和PaO2/FiO2(OR=0.953,95%CI 0.933-0.973,P<0.001)是死亡的独立预测因素。外周血淋巴细胞<0.65×10⁹/L或APACHE II评分>14的患者预后不良风险更高。

要点

  • 流感相关急性呼吸衰竭成人患者医院病死率高达39.4%(41/104),91.3%为甲型流感感染。
  • 入ICU时APACHE II评分>14的患者预后不良风险更高,多因素分析中APACHE II评分OR=1.195(95%CI 1.041-1.372,P=0.011)。
  • 入ICU时外周血淋巴细胞计数<0.65×10⁹/L提示预后不良风险更高,多因素分析中OR=0.063(95%CI 0.011-0.369,P=0.002)。
  • 入ICU时PaO2/FiO2是死亡的独立预测因素(OR=0.953,95%CI 0.933-0.973,P<0.001),死亡组PaO2/FiO2为131.8±34.5 mmHg,存活组为181.7±31.6 mmHg。
  • 死亡组侵入性机械通气比例63.4%(26/41)显著高于存活组17.5%(11/63),P<0.01。

适用人群与场景

  • 2018年1月至2020年1月郑州大学第一附属医院和郑州市第六人民医院ICU收治的成人(≥18岁)确诊流感感染合并急性呼吸衰竭患者,共104例。
  • 67例(64.4%)有基础疾病;91.3%(95例)为甲型流感病毒感染。

诊断标准与关键阈值

  • 诊断标准:确诊流感感染(原文未详述具体检测方法)合并急性呼吸衰竭,收住ICU。
  • 预后风险分层阈值:外周血淋巴细胞计数<0.65×10⁹/L或APACHE II评分>14提示预后不良风险更高。
  • 多因素分析中独立预测因素:APACHE II评分(OR=1.195,95%CI 1.041-1.372,P=0.011)、淋巴细胞计数(OR=0.063,95%CI 0.011-0.369,P=0.002)、PaO2/FiO2(OR=0.953,95%CI 0.933-0.973,P<0.001)。

处置流程与药物剂量

  • 原文未提及具体的抗病毒药物方案、剂量、给药途径或疗程。
  • 原文未提及具体的呼吸支持策略(如机械通气模式、参数设置、俯卧位通气等)或目标值。
  • 原文未提及具体的液体复苏、血管活性药物或镇静镇痛方案。

红旗征与不能漏的情况

  • 入ICU时APACHE II评分>14提示预后不良风险更高。
  • 入ICU时外周血淋巴细胞计数<0.65×10⁹/L提示预后不良风险更高。
  • 入ICU时PaO2/FiO2降低(死亡组131.8±34.5 mmHg vs 存活组181.7±31.6 mmHg,P<0.01)提示氧合障碍严重。
  • 死亡组呼吸频率更高(26.0±5.6次/min vs 23.7±5.0次/min,P<0.01),心血管疾病比例更高(24.4% vs 7.9%,P<0.01),PCT更高[0.82(0.23, 4.63)μg/L vs 0.39(0.11, 0.92)μg/L,P<0.01]。

研究设计与关键结果

  • 研究类型:回顾性分析,两家中心(郑州大学第一附属医院和郑州市第六人民医院),样本量104例,人群为ICU收治的成人流感感染合并急性呼吸衰竭患者。
  • 主要终点:医院病死率39.4%(41/104);存活组63例,死亡组41例。
  • 死亡组vs存活组入ICU时:APACHE II评分18.20±4.88 vs 12.35±4.58,PaO2/FiO2 131.8±34.5 mmHg vs 181.7±31.6 mmHg,淋巴细胞计数0.53±0.40×10⁹/L vs 0.92±0.44×10⁹/L,血红蛋白105.66±28.17 g/L vs 118.29±28.29 g/L,血小板计数135.12±85.40×10⁹/L vs 199.81±110.11×10
  • 死亡组住院时间更短[7.0(4.0, 11.0)天 vs 12.0(8.0, 20.0)天,P<0.01]。
  • 多因素Logistic分析:APACHE II评分(OR=1.195,95%CI 1.041-1.372,P=0.011)、淋巴细胞计数(OR=0.063,95%CI 0.011-0.369,P=0.002)、PaO2/FiO2(OR=0.953,95%CI 0.933-0.973,P<0.001)为死亡的独立预测因素。
  • 外周血淋巴细胞计数与T淋巴细胞、CD4+、CD8+计数呈正相关(r分别为0.593、0.563、0.500,均P<0.001)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(原文标注为回顾性分析),非RCT。
  • 证据等级:原文未提及。
  • 局限:原文未明确提及局限;设计本身为单国两中心回顾性研究,样本量104例,可能存在选择偏倚和未测量混杂。

对床旁实践的改变

  • 对ICU收治的流感相关急性呼吸衰竭成人患者,入ICU时应评估APACHE II评分、PaO2/FiO2和外周血淋巴细胞计数以辅助预后分层。
  • APACHE II评分>14或淋巴细胞计数<0.65×10⁹/L的患者预后不良风险更高,应加强监测和积极治疗。
  • 低PaO2/FiO2提示氧合障碍严重,死亡风险增加,应优化呼吸支持策略。
  • 原文未提供具体治疗干预(抗病毒、机械通气、免疫调节等)对预后的影响数据,不能据此改变具体治疗措施。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the clinical characteristics and prognostic predictors of adult patients with acute respiratory failure due to influenza infection.

METHODS: A retrospective analysis was performed on adult patients with acute respiratory failure due to confirmed influenza infection admitted to intensive care units (ICU) of the First Affiliated Hospital of Zhengzhou University and the Sixth People's Hospital of Zhengzhou between January 2018 and January 2020. The subjects were divided into survival and death groups according to whether the patients died before discharge. Demographic and clinical data including underlying conditions, laboratory variables, therapy and prognostic factors of hospital mortality between the two groups were analyzed. The risk factors of mortality were evaluated by univariate and multivariate Logistic regression analysis. Then, the correlation between lymphocyte (LYM) count and LYM subsets were analyzed. The survival rates of different acute physiologic and chronic health evaluation II (APACHE II) and LYM level subgroups were compared.

RESULTS: A total of 104 patients were enrolled. Among them, 67 cases (64.4%) had underlying conditions, 91.3% of the patients (95 cases) were infected by influenza A virus, and the hospital mortality rate was 39.4% (41 cases). Compared with survival group, the patients of death group had higher respiratory rate (times/min: 26.0±5.6 vs. 23.7±5.0), APACHE II score (18.20±4.88 vs. 12.35±4.58), procalcitonin [PCT (μg/L): 0.82 (0.23, 4.63) vs. 0.39 (0.11, 0.92)], higher percentage of cardiovascular disease [24.4% (10/41) vs. 7.9% (5/63)] and invasive mechanical ventilation [63.4% (26/41) vs. 17.5% (11/63), all P < 0.01], but had lower oxygenation index [PaO2/FiO2 (mmHg, 1 mmHg = 0.133 kPa): 131.8±34.5 vs. 181.7±31.6] at ICU admission, LYM (×109/L: 0.53±0.40 vs. 0.92±0.44), hemoglobin [Hb (g/L): 105.66±28.17 vs. 118.29±28.29], platelet count [PLT (×109/L): 135.12±85.40 vs. 199.81±110.11], T lymphocyte count [cells/μL: 181 (131, 275) vs. 319 (238, 528)], CD4+ count [cells/μL: 110 (71, 161) vs. 190 (120, 311)] and CD8+ count [cells/μL: 71 (33, 100) vs. 121 (81, 188), all P < 0.01]. Patients of death group also had a shorter length of hospital stay [days: 7.0 (4.0, 11.0) vs. 12.0 (8.0, 20.0), P < 0.01]. Univariate analysis showed that APACHE II score [odds ratio (OR) = 1.207, 95% confidence interval (95%CI) was 1.094-1.332, P < 0.001], LYM (OR = 0.070, 95%CI was 0.018-0.271, P < 0.001), Hb (OR = 0.984, 95%CI was 0.970-0.999, P = 0.031), PLT (OR = 0.992, 95%CI was 0.987-0.997, P = 0.003), T lymphocyte count (OR = 0.996, 95%CI was 0.993-0.998, P = 0.001) and PaO2/FiO2 (OR = 0.955, 95%CI was 0.938-0.972, P < 0.001) were the risk factors for the prognosis of influenza patients with acute respiratory failure. Further multivariate Logistic analysis also showed that APACHE II score (OR = 1.195, 95%CI was 1.041-1.372, P = 0.011), LYM (OR = 0.063, 95%CI was 0.011-0.369, P = 0.002) and PaO2/FiO2 (OR = 0.953, 95%CI was 0.933-0.973, P < 0.001) were the predictors of mortality. Moreover, patients with peripheral blood LYM < 0.65×109/L or APACHE II score > 14 had a higher risk of poor outcome. There were significantly positive correlation between LYM and LYM subsets (T lymphocyte, CD4+ and CD8+ lymphocyte, r value was 0.593, 0.563, and 0.500, respectively, all P < 0.001).

CONCLUSIONS: Influenza patients with acute respiratory failure were critically ill and had a high mortality rate. APACHE II score, PaO2/FiO2 and LYM at ICU admission were independent risk factors affecting the prognosis of patients.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Duan J, Yang Y, Hou S, et al. [Clinical characteristics and prognostic factors of adult patients with acute respiratory failure due to influenza infection]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33463487. doi:10.3760/cma.j.cn121430-20200827-00598

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。